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Heroes of adversity
Our very human default position when it comes to public 
sector healthcare delivery is to bemoan the inefficiencies, 
corruption, cadre deployment and financial mismanagement 
that beset and befuddle the best intentions of the truly vocation-
driven healthcare professional. It can easily blind us to the 
tremendous creativity and innovation that many of our public 
sector colleagues display when rising to the challenges posed 
by these realities – and by the shift in funding away from 
the tertiary sector to the primary health sector. Izindaba has 
profiled many such uplifting stories and this month focuses 
on Tygerberg Hospital’s neonatology team, who have halved 
deaths of underweight newborn babies in their facility by 
creating intelligent, alert and highly practical alternatives to 
the overworked and scarce life-saving ventilators in a hugely 
shrunken paediatric intensive care unit.1 It’s so replicable that 
secondary and district hospitals across the Western Cape are 
ordering the relatively inexpensive home-built nasal continuous 
positive airways pressure (nCPAP) machines from Tygerberg’s 
workshop and adopting their holistic best-practice mother and 
child treatment protocols. Result? Hundreds of tiny lives saved 
annually. Extrapolate the possibilities by considering just one 
cherry-picked fact: nationally in the first five months of 2010, 
some 8 000 infant deaths were recorded in the public sector.
Time for that ’flu shot
This issue offers the usual recommendations for influenza 
vaccination ahead of the winter season.2 According to a recent 
report,3 the vaccine is useful in only approximately 60% of recipients, 
and least useful in persons over 65; nevertheless, Osterholm, chief 
author of the report, says: ‘Use this vaccine … the safety profile 
is actually quite good. But we have oversold it. Use it – but just 
know it’s not going to work nearly as well as everyone says.’4 There 
is also useful guidance for antiviral chemotherapy in the form 
of oseltamivir or zanamivir, to which novel influenza A (H1N1) 
and H3N2 and B influenza viruses remain largely sensitive; recent 
World Health Organization recommendations advise treatment 
immediately on suspicion of infection for high-risk (severely 
immuno-compromised) individuals exposed to influenza with a 
5-day course.
Hazards of spinal anaesthesia
For the first time, the Report on Confidential Enquiries into Maternal 
Deaths in South Africa (2008 - 2010) documents an increasing 
number of deaths associated with spinal anaesthesia for caesarean 
section (CS).5 Because of the misconception that spinal anaesthesia is 
inherently safe, it is administered by doctors neither fully trained nor 
competent in the management of anaesthetic complications. Worse, 
the decision to use it is made not because it is the optimal form of 
anaesthesia for a given situation, but because it is the only form the 
doctor feels ‘competent’ to provide. Compounding the problem is the 
belief that the patient, once anaesthetised, can be left to be monitored 
by medically unqualified personnel and the doctor freed to perform 
the surgery. This ‘abandonment’ of the patient was the direct cause of 
death in 6% of 92 anaesthetic deaths documented in the 2008 - 2010 
report.
Units that cannot monitor and stabilise their patients during any 
anaesthetic (of whatever variety) by a doctor (who must not be given 
the additional tasks of assisting at the surgery or resuscitating the 
baby) should be referring their operative obstetric cases to the nearest 
available unit that can.
Childhood cancer in Ivory Coast
As an African medical journal, the SAMJ welcomes the opportunity 
to publish original research from other countries in Africa. A 
collaborative study from colleagues at Tygerberg Hospital and 
the departments of Pediatrics and Haematology at the University 
Hospital of Treichville, Abidjan, offers insight into the status of 
oncology services in Côte d’Ivoire.6
A survey carried out among children (<18 years of age) over 
the decade January 1995 - December 2004 showed that Burkitt’s 
lymphoma was the most common malignancy (73.6%), followed by 
nephroblastoma (14.5%) and acute leukaemia (4%). An abdominal 
mass and swelling of the jaw were the most common clinical 
presentations. As might be expected, delay in diagnosis was 
common, resulting in delay in treatment – almost 40% died due to 
advanced disease shortly after admission. Half of the patients were 
lost to follow-up. The overall survival rate was only 10%.
But there is good news. In 2004, the Pediatric Hematology 
Oncology Unit in Côte d’Ivoire joined the Franco-African Group 
of Paediatric Oncology. Treatment now follows established 
common protocols, chemotherapy is free, and there is access to 
sophisticated radiology.
Retinopathy of prematurity (ROP)
SA has become part of the so-called ‘third epidemic of ROP’ as 
more premature infants survive with improved neonatal care. As in 
other middle-income countries, babies of higher birth weight are at 
risk, because units that treat these infants may not have the skills or 
equipment to monitor oxygen appropriately. In addition, resources to 
identify infants at risk for ROP may be inadequate.
Centres in SA academic institutions have appropriate neonatal 
care facilities and are able to screen their high-risk infants. As a 
result, they have an acceptably low incidence of ROP. This is not the 
case in smaller, less well-resourced hospitals, for which, however, 
research offers useful pointers in terms of those infants who should 
be screened.7
A consensus guideline by paediatricians, neonatologists and 
ophthalmologists in both state and private practice8 is published for 
the SA context and is intended to ensure appropriate neonatal care of 
infants at risk. A screening protocol is proposed.
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